193 related articles for article (PubMed ID: 17496421)
1. A case of 3beta-hydroxysteroid dehydrogenase type II (HSD3B2) deficiency picked up by neonatal screening for 21-hydroxylase deficiency: difficulties and delay in etiologic diagnosis.
Nordenström A; Forest MG; Wedell A
Horm Res; 2007; 68(4):204-8. PubMed ID: 17496421
[TBL] [Abstract][Full Text] [Related]
2. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.
Simard J; Moisan AM; Morel Y
Semin Reprod Med; 2002 Aug; 20(3):255-76. PubMed ID: 12428206
[TBL] [Abstract][Full Text] [Related]
3. A novel homozygous nonsense mutations E135* in the type II 3beta-hydroxysteroid dehydrogenase gene in a girl with salt-losing congenital adrenal hyperplasia. Mutations in brief no. 168. Online.
Marui S; Torrealba IM; Russell AJ; Latronico AC; Sutcliffe RG; Mendonca BB
Hum Mutat; 1998; 12(2):139. PubMed ID: 10694926
[TBL] [Abstract][Full Text] [Related]
4. A novel homozygous Q334X mutation in the HSD3B2 gene causing classic 3β-hydroxysteroid dehydrogenase deficiency: an unexpected diagnosis after a positive newborn screen for 21-hydroxylase deficiency.
Jeandron DD; Sahakitrungruang T
Horm Res Paediatr; 2012; 77(5):334-8. PubMed ID: 22343390
[TBL] [Abstract][Full Text] [Related]
5. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency.
Johannsen TH; Mallet D; Dige-Petersen H; Müller J; Main KM; Morel Y; Forest MG
J Clin Endocrinol Metab; 2005 Apr; 90(4):2076-80. PubMed ID: 15671104
[TBL] [Abstract][Full Text] [Related]
6. A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS.
Peter M; Janzen N; Sander S; Korsch E; Riepe FG; Sander J
Horm Res; 2008; 69(4):253-6. PubMed ID: 18204274
[TBL] [Abstract][Full Text] [Related]
7. [Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase deficiency].
Marunová M
Vnitr Lek; 2006 Oct; 52(10):957-62. PubMed ID: 17063810
[TBL] [Abstract][Full Text] [Related]
8. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
[TBL] [Abstract][Full Text] [Related]
9. New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes.
Moisan AM; Ricketts ML; Tardy V; Desrochers M; Mébarki F; Chaussain JL; Cabrol S; Raux-Demay MC; Forest MG; Sippell WG; Peter M; Morel Y; Simard J
J Clin Endocrinol Metab; 1999 Dec; 84(12):4410-25. PubMed ID: 10599696
[TBL] [Abstract][Full Text] [Related]
10. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
Lutfallah C; Wang W; Mason JI; Chang YT; Haider A; Rich B; Castro-Magana M; Copeland KC; David R; Pang S
J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
[TBL] [Abstract][Full Text] [Related]
11. [3Beta-hydroxysteroid dehydrogenase deficiency].
Goto Y; Yanase T
Nihon Rinsho; 2006 May; Suppl 1():685-8. PubMed ID: 16776248
[No Abstract] [Full Text] [Related]
12. High 17-hydroxyprogesterone level in newborn screening test for congenital adrenal hyperplasia.
Levy-Shraga Y; Pinhas-Hamiel O
BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26912766
[TBL] [Abstract][Full Text] [Related]
13. Variants of the type II 3beta-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents.
Nayak S; Lee PA; Witchel SF
Mol Genet Metab; 1998 Jul; 64(3):184-92. PubMed ID: 9719627
[TBL] [Abstract][Full Text] [Related]
14. Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.
Mermejo LM; Elias LL; Marui S; Moreira AC; Mendonca BB; de Castro M
J Clin Endocrinol Metab; 2005 Mar; 90(3):1287-93. PubMed ID: 15585552
[TBL] [Abstract][Full Text] [Related]
15. A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty.
Alos N; Moisan AM; Ward L; Desrochers M; Legault L; Leboeuf G; Van Vliet G; Simard J
J Clin Endocrinol Metab; 2000 May; 85(5):1968-74. PubMed ID: 10843183
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal mutations in 3beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia.
Welzel M; Wüstemann N; Simic-Schleicher G; Dörr HG; Schulze E; Shaikh G; Clayton P; Grötzinger J; Holterhus PM; Riepe FG
J Clin Endocrinol Metab; 2008 Apr; 93(4):1418-25. PubMed ID: 18252794
[TBL] [Abstract][Full Text] [Related]
17. 3β-hydroxysteroid dehydrogenase type II deficiency on newborn screening test.
Araújo VG; Oliveira RS; Gameleira KP; Cruz CB; Lofrano-Porto A
Arq Bras Endocrinol Metabol; 2014 Aug; 58(6):650-5. PubMed ID: 25211449
[TBL] [Abstract][Full Text] [Related]
18. [Congenital adrenal hyperplasia salt-wasting form in males during the neonatal period. Can we anticipate to metabolic emergency?].
Gebara E; Fernández MA; Rojas E; Amin A; López MR
Arch Argent Pediatr; 2009 Aug; 107(4):369-73. PubMed ID: 19753447
[TBL] [Abstract][Full Text] [Related]
19. The incidence of congenital adrenal hyperplasia in Switzerland--a survey of patients born in 1960 to 1974.
Werder EA; Siebenmann RE; Knorr-Mürset G; Zimmermann A; Sizonenko PC; Theintz P; Girard J; Zachmann M; Prader A
Helv Paediatr Acta; 1980 Mar; 35(1):5-11. PubMed ID: 6967865
[TBL] [Abstract][Full Text] [Related]
20. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
Zhang L; Sakkal-Alkaddour H; Chang YT; Yang X; Pang S
J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
